RecruitingNCT02660645
Blue Light Cystoscopy With Cysview® Registry
Sponsor
Photocure
Enrollment
4,400 participants
Start Date
Apr 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is a registry tracking the use of blue light cystoscopy with a dye called Cysview (hexaminolevulinate) — a technique that makes bladder cancer cells glow pink/violet under a special light — to see how well it works in real-world clinical practice for detecting bladder cancer.
**You may be eligible if...**
- You are scheduled for a cystoscopy (a procedure to look inside the bladder with a camera) for bladder cancer evaluation
- Your doctor plans to use blue light cystoscopy with Cysview during your procedure
- You are at least 18 years old
- You consent to have your procedure data included in the registry
**You may NOT be eligible if...**
- You are allergic to hexaminolevulinate (Cysview) or related compounds
- You have porphyria (a rare metabolic disorder)
- You are pregnant
- You have gross blood in your urine at the time of the procedure (which could interfere with imaging)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGHexaminolevulinate hydrochloride (HCL)
Instillation in bladder
DEVICEKarl Storz D-Light C Photodynamic Diagnostic (PDD) system
Cystoscopy procedure
Locations(23)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02660645
Related Trials
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
NCT065031461 location
Evaluation for NCI Surgery Branch Clinical Research Protocols
NCT000018231 location
DESTINY-PANTUMOUR04
NCT0712400017 locations
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT000268841 location
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
NCT0741929521 locations